Murthy V, Kashid S, Pal M, Vadassery A, Maitre P, Arora A
BMJ Oncol. 2025; 3(1):e000435.
PMID: 39886177
PMC: 11347679.
DOI: 10.1136/bmjonc-2024-000435.
Mastroianni R, Iannuzzi A, Ragusa A, Flammia R, Tuderti G, Anceschi U
World J Urol. 2024; 42(1):484.
PMID: 39143260
DOI: 10.1007/s00345-024-05187-8.
Cho S, Lim S, Kwon G, Kim C, Park W, Pyo H
Cancer Res Treat. 2024; 56(3):893-897.
PMID: 38374699
PMC: 11261190.
DOI: 10.4143/crt.2024.015.
Bahlburg H, Reicherz A, Reike M, Bach P, Butea-Bocu M, Tully K
J Cancer Surviv. 2024; .
PMID: 38291220
DOI: 10.1007/s11764-024-01535-0.
Zhou Q, Chen X, Chen Q, Hao L
Cancer Control. 2023; 30:10732748231212353.
PMID: 37907433
PMC: 10621294.
DOI: 10.1177/10732748231212353.
Management of urinary incontinence after radical cystectomy and orthotopic neobladder: A scoping review of international practices.
Miao S, He Q, Zhang Y, Wang L, Jin X, Bao C
Nurs Open. 2023; 10(10):6618-6634.
PMID: 37408112
PMC: 10495704.
DOI: 10.1002/nop2.1924.
Psychosocial distress and quality of life in patients after radical cystectomy - one year follow-up in 842 German patients.
Bahlburg H, Hellmann T, Tully K, Butea-Bocu M, Reike M, Roghmann F
J Cancer Surviv. 2023; 18(5):1600-1607.
PMID: 37162683
PMC: 11424671.
DOI: 10.1007/s11764-023-01400-6.
Health-related quality of life after curative treatment for muscle-invasive bladder cancer.
Grobet-Jeandin E, Pinar U, Parra J, Roupret M, Seisen T
Nat Rev Urol. 2023; 20(5):279-293.
PMID: 36653671
DOI: 10.1038/s41585-022-00693-z.
Tyro3 Targeting as a Radiosensitizing Strategy in Bladder Cancer through Cell Cycle Dysregulation.
Silina L, Dufour F, Rapinat A, Reyes C, Gentien D, Maksut F
Int J Mol Sci. 2022; 23(15).
PMID: 35955805
PMC: 9368768.
DOI: 10.3390/ijms23158671.
The relationship between type of urinary diversion and quality of life after radical cystectomy: Ileal conduit versus orthotopic bladder.
Elbadry M, Ali A, Hassan A, Clement K, Hammady A, Abdbelaal A
BJUI Compass. 2022; 1(4):133-138.
PMID: 35474941
PMC: 8988837.
DOI: 10.1002/bco2.29.
Neoadjuvant chemotherapy with gemcitabine and cisplatin followed by selective bladder preservation chemoradiotherapy in muscle-invasive urothelial carcinoma of bladder.
Sung H, Kim H, Kim R, Kim C, Kwon G, Park W
Investig Clin Urol. 2022; 63(2):168-174.
PMID: 35244990
PMC: 8902424.
DOI: 10.4111/icu.20210407.
Penile implant infection factors: a contemporary narrative review of literature.
Baird B, Parikh K, Broderick G
Transl Androl Urol. 2021; 10(10):3873-3884.
PMID: 34804829
PMC: 8575569.
DOI: 10.21037/tau-21-568.
Health-related quality of life after radical cystectomy.
Choi H, Park J, Bae J, Tae B
Transl Androl Urol. 2021; 9(6):2997-3006.
PMID: 33457272
PMC: 7807323.
DOI: 10.21037/tau.2020.02.01.
Orthotopic Neobladder Reconstruction: Patient Selection And Perspectives.
Qu L, Lawrentschuk N
Res Rep Urol. 2019; 11:333-341.
PMID: 31850284
PMC: 6912000.
DOI: 10.2147/RRU.S181473.
HRQOL related to urinary diversion in Radical Cystectomy: a systematic review of recent literature.
Pazeto C, Baccaglini W, Tourinho-Barbosa R, Glina S, Cathelineau X, Sanchez-Salas R
Int Braz J Urol. 2019; 45(6):1094-1104.
PMID: 31808396
PMC: 6909868.
DOI: 10.1590/S1677-5538.IBJU.2018.0858.
Recovering from Cystectomy: Patient Perspectives.
McMullen C, Kwan M, Colwell J, Munneke J, Davis J, Firemark A
Bladder Cancer. 2019; 5(1):51-61.
PMID: 30854413
PMC: 6401661.
DOI: 10.3233/BLC-180202.
Quality of life in bladder cancer patients receiving medical oncological treatment; a systematic review of the literature.
Taarnhoj G, Johansen C, Pappot H
Health Qual Life Outcomes. 2019; 17(1):20.
PMID: 30670040
PMC: 6341712.
DOI: 10.1186/s12955-018-1077-6.
Bladder Cancer Survivorship.
Bhanvadia S
Curr Urol Rep. 2018; 19(12):111.
PMID: 30414013
DOI: 10.1007/s11934-018-0860-6.
Urinary function following radical cystectomy and orthotopic neobladder urinary reconstruction.
Nayak A, Cagiannos I, Lavallee L, Morash C, Hickling D, Mallick R
Can Urol Assoc J. 2018; 12(6):181-186.
PMID: 29485037
PMC: 5994980.
DOI: 10.5489/cuaj.4877.
Trends in urinary diversion after radical cystectomy for urothelial carcinoma.
Bachour K, Faiena I, Salmasi A, Lenis A, Johnson D, Pooli A
World J Urol. 2018; 36(3):409-416.
PMID: 29299664
DOI: 10.1007/s00345-017-2169-3.